Post by KNCV TB Plus

The challenge of tackling #AntimicrobialResistance (AMR) goes far beyond developing new antibiotics and we are taking part in these conversations. 📅Last week, our colleagues Kristin Kremer and Agnes Gebhard joined the #AMRGlobal Partners Meeting. This meeting brought together innovators from different industries: academia, biotech, NGOs, private sector and more. Together, they explored the latest results in #AMR research and discussed new, sustainable funding mechanisms needed to protect global health now and in the future. 👉Learn more about AMR Global https://lnkd.in/emh2F8vn 👉Read our latest article on AMR and TB, integrated approaches to tackle the deadly duo https://lnkd.in/eWneijBn